Core Scientific, Inc. Common Stock (CORZ) — Cash Flow Reinvestment Rate

Latest as of March 2026: 1.56x

Core Scientific, Inc. Common Stock (CORZ) has a Cash Flow Reinvestment Rate of 1.56x as of March 2026, reinvesting $389.23 Million (capex $389.23 Million ) from operating cash flow of $249.88 Million. See Core Scientific, Inc. Common Stock (CORZ) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.56x
(Capex + Investments) / Operating CF

Total Reinvested

$389.23 Million
Capex + Investments

Operating Cash Flow

$249.88 Million
USD

Capital Expenditures

$389.23 Million
USD

Core Scientific, Inc. Common Stock Cash Flow Reinvestment Rate (2022–2025)

Historical reinvestment intensity for Core Scientific, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see CORZ cash flow conversion.

Annual Cash Flow Reinvestment Rate for Core Scientific, Inc. Common Stock (2022–2025)

Year-by-year capital reinvestment analysis for Core Scientific, Inc. Common Stock. See CORZ free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 2.62x $729.00 Million $278.25 Million $729.00 Million ▼ -40.9%
2024 4.43x $190.15 Million $42.90 Million $94.96 Million ▲ +1406.7%
2023 0.29x $19.16 Million $65.11 Million $16.16 Million ▼ -90.1%
2022 2.99x $612.51 Million $205.19 Million $601.66 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow